IRIS - Res&Arch Institutional Research Information System - Research & Archive

DI FILIPPO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.087
AS - Asia 3.906
EU - Europa 3.464
SA - Sud America 763
Continente sconosciuto - Info sul continente non disponibili 356
AF - Africa 118
OC - Oceania 6
Totale 14.700
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.768
SG - Singapore 1.771
IT - Italia 780
BR - Brasile 570
CN - Cina 565
RU - Federazione Russa 496
HK - Hong Kong 493
IE - Irlanda 487
VN - Vietnam 406
FR - Francia 278
DE - Germania 253
UA - Ucraina 252
SE - Svezia 244
FI - Finlandia 174
GB - Regno Unito 145
KR - Corea 119
CA - Canada 116
BD - Bangladesh 113
IN - India 79
RO - Romania 64
AR - Argentina 58
NL - Olanda 55
MX - Messico 48
TR - Turchia 47
ID - Indonesia 42
CZ - Repubblica Ceca 40
IQ - Iraq 40
JP - Giappone 39
PL - Polonia 39
CO - Colombia 33
ZA - Sudafrica 33
EC - Ecuador 32
PK - Pakistan 29
NI - Nicaragua 28
AT - Austria 25
BE - Belgio 25
SA - Arabia Saudita 25
VE - Venezuela 24
UZ - Uzbekistan 22
ES - Italia 20
IL - Israele 20
GT - Guatemala 18
CR - Costa Rica 17
JM - Giamaica 17
PH - Filippine 17
SC - Seychelles 16
TT - Trinidad e Tobago 16
PR - Porto Rico 15
CW - ???statistics.table.value.countryCode.CW??? 14
PY - Paraguay 14
LT - Lituania 13
MA - Marocco 13
TN - Tunisia 13
CH - Svizzera 12
CL - Cile 12
HN - Honduras 12
LB - Libano 12
GR - Grecia 11
HR - Croazia 9
AE - Emirati Arabi Uniti 7
KE - Kenya 7
KZ - Kazakistan 7
SV - El Salvador 7
BG - Bulgaria 6
BO - Bolivia 6
EG - Egitto 6
ET - Etiopia 6
GP - Guadalupe 6
PE - Perù 6
UY - Uruguay 6
DZ - Algeria 5
JO - Giordania 5
MY - Malesia 5
PA - Panama 5
PT - Portogallo 5
TW - Taiwan 5
AZ - Azerbaigian 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CG - Congo 4
KG - Kirghizistan 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IR - Iran 3
NP - Nepal 3
OM - Oman 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
BW - Botswana 2
BZ - Belize 2
DK - Danimarca 2
EE - Estonia 2
EU - Europa 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
Totale 14.314
Salva come PNG Salva come JPEG
Città #
Singapore 1.276
San Jose 596
Chandler 512
Ashburn 509
Hong Kong 491
Dublin 485
Perugia 277
Santa Clara 257
Boardman 230
San Mateo 220
Council Bluffs 208
Moscow 174
Beijing 155
Altamura 139
Jacksonville 133
Lauterbourg 129
Dong Ket 121
Princeton 120
Los Angeles 119
Seoul 119
Munich 112
Medford 111
Lawrence 106
Wilmington 93
Ho Chi Minh City 90
Andover 86
New York 85
Ann Arbor 81
The Dalles 68
Des Moines 62
Dallas 60
Hanoi 56
Piscataway 56
Phoenix 55
Turku 54
North Bergen 50
São Paulo 48
Helsinki 43
Frankfurt am Main 41
Redmond 40
Tokyo 36
Bucharest 35
Rome 35
Falls Church 34
Atlanta 31
Orem 30
Brooklyn 29
Chicago 29
Carrboro 28
Montreal 28
Brno 27
Denver 27
Managua 27
Warsaw 26
Chennai 25
Houston 25
Saint Petersburg 25
Milan 23
Boston 22
Amsterdam 21
London 21
Brussels 20
Norwalk 20
Nuremberg 20
Johannesburg 19
San Francisco 19
Buffalo 18
Redwood City 18
Stockholm 17
Woodbridge 17
Charlotte 16
Guatemala City 16
Haiphong 16
Quito 16
Rio de Janeiro 16
Toronto 16
Vienna 16
Columbus 15
Kingston 14
Ankara 13
Hefei 13
Manchester 13
Poplar 13
Tashkent 13
Willemstad 13
Florence 12
San José 12
Timisoara 12
Brasília 11
Izmir 11
Mexico City 11
Naples 11
Riyadh 11
Biên Hòa 10
Da Nang 10
Dhaka 10
Guangzhou 10
Riverbank 10
Verona 10
Baghdad 9
Totale 8.798
Salva come PNG Salva come JPEG
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 230
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 186
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 179
Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis 160
Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis 157
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 155
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 147
"Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study 143
Hippocampal epileptogenesis in autoimmune encephalitis 143
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 143
Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. 139
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 137
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 136
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis 135
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 134
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 132
2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes 130
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 130
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 129
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 128
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 126
Visual pathway involvement in multiple sclerosis: Look straight in the eyes 126
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 124
Plasticity and repair in the post-ischemic brain 124
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 123
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 122
A microbially produced AhR ligand promotes a Tph1-driven tolerogenic program in multiple sclerosis 121
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 121
Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency 121
Lower urinary tract symptoms and urodynamic dysfunction in clinically isolated syndromes suggestive of multiple sclerosis 117
ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? 116
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2 116
Ischemic bilateral hippocampal dysfunction during transient global amnesia. 115
Psychiatric symptoms in multiple sclerosis: a biological perspective on synaptic and network dysfunction 114
A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: the RESPECT study 113
Beyond clinical changes: Rehabilitation-induced neuroplasticity in MS 112
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 112
Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis. 111
Treatment of multiple sclerosis relapses with high-dose methylprednisolone reduces the evolution of contrast-enhancing lesions into persistent black holes 111
La disfunzione sessuale nei pazienti con sclerosi multipla: prevalenza e impatto dei trattamenti sintomatici 110
A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. 109
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 109
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 108
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 108
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 107
Basi neurobiologiche dei deficit cognitivi nella malattia di Parkinson 107
Direct and indirect pathways of basal ganglia: a critical reappraisal. 107
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 106
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 106
Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis 106
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 105
Mitochondria and the link between neuroinflammation and neurodegeneration. 104
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 103
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 101
A young patient with type C multiple system atrophy and hereditary hemochromatosis. 101
Synaptic dysfunction in multiple sclerosis: A red thread from inflammation to network disconnection 101
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 101
A pathophysiological link between dystonia, striatal interneurons and neuropeptide Y 100
Host and Microbial Tryptophan Metabolic Profiling in Multiple Sclerosis 100
Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature 100
Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: A multicentre retrospective study 99
Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. 98
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis 98
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 97
Does cerebrospinal fluid neurofilament light chain correlate with psychiatric symptoms severity in multiple sclerosis? 96
Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain 95
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics 94
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 93
Neurofilament light chain as a biomarker in neurological disorders 93
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 92
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap. 92
The endocannabinoid system in Parkinson's disease. 91
Teaching NeuroImages: Acute tetraparesis: Mind the brain 91
Short-term and long-term plasticity at corticostriatal synapses: Implications for learning and memory. 91
Distinct levels of dopamine denervation differentially alter striatal synapticplasticity and NMDA receptor subunit composition. 90
Recurrent hyperCKemia with normal muscle biopsy in a pediatric patient with neuromyelitis optica 90
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. 90
CSF synaptic biomarkers and cognitive impairment in multiple sclerosis 89
Parkinsonism and cognitive impairment following chronic exposure to potassium cyanide. 89
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors 89
CSF proteome analysis in multiple sclerosis patients by two-dimensional electrophoresis. 89
The no evidence of disease activity (NEDA) concept in MS: impact of spinal cord MRI 89
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop) 88
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 88
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 87
An “all-wheel drive” proposal to accelerate clinical research in common and rare neurological diseases 87
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose 86
Multiple sclerosis and cognition: synaptic failure and network dysfunction 86
Intrathecal B cell activation and memory impairment in multiple sclerosis 85
Cytokines, synaptic plasticity and network dynamics: a matter of balance 85
Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. 85
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 85
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline 85
Impact of post-contrast MRI in the definition of active multiple sclerosis 84
Cerebrospinal fluid interferon-γ and development of depression in multiple sclerosis 84
Finding a way to preserve mitochondria: New pathogenic pathways in experimental multiple sclerosis 84
CSF biomarkers of B-cell activation in multiple sclerosis: a clinical perspective 83
Sensitization, glutamate, and the link between migraine and fibromyalgia. 83
Ischemic stroke injury is mediated by aberrant Cdk5 83
Characteristics and treatment of Multiple Sclerosis-related trigeminal neuralgia: An Italian multi-centre study 83
Totale 10.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.079
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022790 0 0 0 0 49 31 13 290 21 82 158 146
2022/20231.742 119 373 23 152 124 188 6 58 627 4 51 17
2023/2024918 38 84 33 61 6 2 164 13 122 32 162 201
2024/20252.227 27 203 82 106 230 175 112 209 390 136 364 193
2025/20265.293 361 368 288 772 705 493 813 276 520 405 192 100
2026/20271.970 134 196 391 1.065 184 0 0 0 0 0 0 0
Totale 14.700